Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Malaysia Team Up to Promote Biotech

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today signed a memorandum of understanding with the Malaysian government to promote and develop biotechnology in that country.

The MOU was reached through the Malaysian Institute of Pharmaceuticals and Nutraceuticals, or IPHARM, an agency under the Ministry of Science, Technology, and Innovation.

The alliance will focus on establishing the IPHARM-Agilent Global Reference Research Lab and developing human capital in biotechnology, Agilent said in a statement. The lab will develop global Halal testing standards in pharmaceuticals and nutraceuticals and provide access to analytical tools and expertise "to develop the local industry and small and medium enterprise ecosystem in their commercialization efforts," the company added.

Halal is a term designating that goods or actions comply with Islamic laws.

Agilent will provide its specialized technical expertise to create the lab and "leading-edge analytical and application solutions to jointly develop the global Halal testing standards with IPHARM," it said. It also will transfer its biotechnology knowledge to Malaysia "to build and develop indigenous capabilities through an ecosystem of local knowledge partners."

IPHARM contributes domain expertise in bioactive compounds research and analysis, and will leverage Malaysia's "inherited strength in biodiversity and its aspiration to be a global Halal testing leader in pharmaceuticals and nutraceuticals," Agilent said.

Gooi Soon Chai, president of Agilent Technologies Malaysia and Singapore, added that the partnership offers "enormous potential" in hastening biotechnology as Malaysia's next engine of economic growth.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.